JUN 27, 2021 5:49 AM PDT

Are e-cigarettes actually helpful for smoking cessation?

New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarettes. The study considered how dual users (who smoke both e-cigarettes and tobacco cigarettes) could use e-cigarettes to aid in smoking cessation. Almost 41% of the approximately 8 million adults in the U.S. using e-cigarettes are dual users; the study aimed to analyze the impact of e-cigarette use on people who begin using e-cigarettes as a way to wean off of smoking tobacco cigarettes.

"We were concerned that smokers who started vaping in order to quit smoking often ended up instead using both products," said Thomas Brandon, Ph.D., chair of the Health Outcomes & Behavior Department and director of the Tobacco Research and Intervention Program at Moffitt Cancer Center's Tobacco Research and Intervention Program. The concern is that using both e-cigarettes as a transition to stop using tobacco cigarettes ultimately only increases nicotine dependence and exposure to toxins. "This prompted our team to develop an easy-to-distribute intervention that could enhance dual users' smoking cessation efforts and maintain smoking abstinence."

Brandon collaborated with colleagues from Virginia Commonwealth University; Eastern Virginia Medical School; and the University of Auckland to create a series of "If You Vape" booklets produced from interviews with dual vapers. They then tested out the booklets’ utility by distributing them to almost 2,900 dual users that were categorized into three distinct groups: a control group that did not receive any intervention, a group that received standard smoking cessation materials, and a group that received the targeted intervention "If You Vape" booklets.

They found that the participants in the targeted intervention group demonstrated smoking abstinence rates from 5-10% higher than the control group and the standard group over the follow-up period of 18 months. The team also observed that more dependent smokers showed the highest percentage of benefit.

"Our study indicates that dual users could benefit from specific interventions that leverage their ongoing e-cigarette use, which in turn could expand the public health potential of e-cigarettes," said Brandon. "I think it is important to note that while our materials did not endorse the initiation of vaping, it also didn't demonize use. We treated vapers with respect and passed along information to help them achieve their goal of quitting smoking."

In the future, the team plans to continue their investigation to consider the impacts of alternative intervention modalities that could include a mobile application or trying the intervention in clinical settings.

Sources: The Lancet Public Health, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 14, 2021
Cancer
Fighting back against medulloblastoma with naturally-occurring compound
APR 14, 2021
Fighting back against medulloblastoma with naturally-occurring compound
Renewed hope for young children with medulloblastoma comes in the form of a research paper published from the Queen Mary ...
APR 19, 2021
Health & Medicine
Using Artificial Intelligence to Understand the Language of Cancer and Alzheimer's Disease
APR 19, 2021
Using Artificial Intelligence to Understand the Language of Cancer and Alzheimer's Disease
Cancer and Alzheimer’s disease are life-changing, and there is still much we don’t understand about what cau ...
MAY 23, 2021
Neuroscience
Study Links Alcohol Consumption to a Decline in Brain Health
MAY 23, 2021
Study Links Alcohol Consumption to a Decline in Brain Health
Thinking of cracking open a cold one this weekend? Researchers from the University of Oxford have identified a connectio ...
JUN 06, 2021
Cancer
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
JUN 06, 2021
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
The most recent results from the CODEBREAK 100 phase 2 clinical trial support the use of the drug sotorasib to reduce tu ...
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
Loading Comments...